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Wild-type (WT) C57BL/6 mice infected intraperitoneally with 5 × 106 Trypanosoma congolense survive for more than 30 days.
C57BL/6 mice deﬁcient in inducible nitric oxide synthase (iNOS−/−)a n di n f e c t e dw i t h1 0 3 or 5 ×10
6 parasites do not control the
parasitemia and survive for only 14 ±7o r6 .8 ± 0.1 days, respectively. Bloodstream trypanosomes of iNOS−/− mice infected with
5 × 106 T. congolense had a signiﬁcantly higher ratio of organisms in the S+G2+M phases of the cell cycle than trypanosomes in
WT mice. We have reported that IgM anti-VSG-mediated phagocytosis of T. congolense by macrophagesinhibits nitric oxide (NO)
synthesisviaCR3(CD11b/CD18).Here,weshowthatduringtheﬁrstparasitemia,butnotatlaterstagesofinfection,T. congolense-
infected CD11b−/− mice produce more NO and have a signiﬁcantly lower parasitemia than infected WT mice. We conclude that
induced NO contributes to the control of parasitemia by inhibiting the growth of the trypanosomes.
1.Introduction
Trypanosoma congolense is a protozoan pathogen of cattle
and other livestock. The parasite causes N’gana in livestock,
one form of the disease complex collectively known as
African trypanosomiases [1]. In the mammalian host, the
whole parasite is covered with a glycoprotein coat of a single
molecular species, called variant surface glycoprotein (VSG)
[2]. In host defense against infection, macrophages play
an important role through their ability to remove speciﬁc
substances from the blood stream via various receptors, such
as complement receptors, Fc-receptors, scavenger receptors,
and mannose receptors [3, 4]. The control of parasitemia in
African trypanosomiasis is mediated by at least two known
mechanisms: (1) antibody-mediated phagocytosis [5–9]a n d
(2) to a lesser degree, by antibody/complement-mediated
lysis [10–13]. A third mechanism, that is, release of trypan-
otoxic NO by macrophages has been demonstrated in vitro
forT. brucei andT. congolense [14–18].TheroleofNOinvivo
has been controversial. We had speculated that NO might
be involved in the control of T. congolense infections [9].
There is evidence that NO does not contribute to control of
T. brucei in vivo [19, 20] but does contribute to control of T.
congolenseinfections [21,22].WefoundthatIgG2aanti-VSG
antibody-mediated phagocytosis of T. congolense enhances
the synthesis of NO by macrophages, whereas IgM anti-
VSG antibody-mediated phagocytosis inhibited synthesis of
NO [7, 14]. The inhibition of NO synthesis apparently
increased with increasing amounts of IgM anti-VSG [14].
We further observed that macrophages of CD11b−/− mice
were much less eﬃcient in phagocytosis of T. congolense
via opsonization by IgM anti-VSG and complement than
macrophages of WT mice, indicating that IgM anti-VSG-
mediated phagocytosis is greatly enhanced by complement
receptor CR3 [7]. Macrophages of CD11b−/− mice, however,
produced much more NO in response to IgM anti-VSG-
mediated phagocytosis than macrophages of WT mice. It
appeared that, during IgM antibody-mediated phagocytosis,
the induced NO synthesis by WT macrophageswas inhibited
by the binding of a parasite component to CD11b [7]. In
other words, it appears that the parasite has developed a
mechanism trying to evade the deleterious eﬀect of NO.
We predicted that CD11b-deﬁcient (CD11b−/−) mice might
control T. congolense infection via NO more eﬃciently than2 Journal of Parasitology Research
infected WT mice [7]. Here, we conﬁrm the ﬁnding of the
involvement of induced NO synthesis in resistance to T.
congolense infections [21, 22] and provide data that induced
NO inhibits the multiplication of T. congolense in vivo.
2.Materialsand Methods
2.1. Mice. Eight-to 10-week-old, female mice deﬁcient in
inducible nitric oxide synthase (iNOS−/−) were purchased
from Jackson laboratories (genetic background: C57BL/6;
strainname: B6.129P2-NOS2).Eight-to 10-week-old,female
CD11b−/− mice were obtained from Jackson Laboratories
(genetic background: C57BL/6; strain name: B6.129S4-
Itgamtm1Myd/J; stock number: 003991). Eight-to 10-week-
old, female C57BL/6 mice and 5- to 8-week-old, female,
Swiss white mice (CD1) were purchased from the Animal
Resource Center of the University of Saskatchewan (Saska-
toon,Canada).Themicewerekeptinpolycarbonatecageson
sawdust and allowed free access to food and water through-
out the experiments, according to the recommendations of
the Canadian Council of Animal Care.
2.2. Parasites, Infections, Parasitemia, and Survival Time. T.
congolense, Trans Mara strain, variant antigenic type (VAT)
TC13 was used in this study. The origin of this parasite
strain has been previously described [23]. Frozen stabilates
of parasites were used for infecting CD1 mice immunosup-
pressed with cyclophosphamide, and passages were made
every third day as described previously [23]. The parasites
puriﬁed from the blood of infected CD1 mice by DEAE-
cellulose chromatography were used for infection [24].
For experiments, mice were infected intraperitoneally (i.p.)
with 103 or 5 × 106 parasites. To determine the degree of
parasitemia, 10μl of blood were collected from the mouse
tail. Parasites were counted in diluted blood samples by the
use of a hemocytometer. Mice showing signs of the terminal
s t a g ew e r ee u t h a n i z e d .
2.3. Spleen Cell Cultures and Cytokine Assays. Spleen cells
of individual mice were cultured in 24-well plates at an
optimal cell density (5 × 106/mL). Supernatant ﬂuids of
the cell cultures were harvested after incubation for 48h.
Culture supernatant ﬂuids were centrifuged for 10min at
1000×g to remove cellular debris, transferred to new tubes,
a n ds t o r e da t– 8 0 ◦C until analysis. The levels of cytokines
(TNF-α, IL-12p40, MCP-1, IFN-γ, and IL-10) in the culture
supernatant ﬂuids were determined by routine sandwich
ELISA by using Immulon-4 plates and Opt EIA ELISA kits
(BD Biosciences Pharmingen, San Diego, CA), according to
the manufacturer’s protocol. Each sample of the cell culture
ﬂuids was tested for cytokines in triplicate.
2.4. Measurement of Nitrite Production. Nitrite concentra-
tions in the culture ﬂuids harvested after 48hr were deter-
mined by the “Griess reagent system” (Promega, Madison,
WI, U.S.A.) as described previously [14]. Brieﬂy, 50μLo f
culture supernatant ﬂuids were incubated with an equal
volume of sulfanilamide solution (1% sulfanilamide (Sigma)
in 5% phosphoric acid (Sigma)) for 5–10min at room
temperature, protected from light. Then 50μlo ft h eN E D
(Sigma) (0.1% N-1-napthylethylenediamine dihydrochlo-
ride in water) was added and incubated for another 10min
at room temperature, protected from light. The absorbance
was measured at 550nm within 30min in a micro-ELISA
reader. Nitrite levels were determined by comparison with a
sodium nitrite (Sigma) standard curve. The sensitivity of the
detection limit of this assay was 2.5μM.
2.5. Inhibition of Inducible Nitric Oxide Synthase. Some
groups of mice were injected intravenously (i.v.) with L-N6-
(1-imminoethyl) lysine (L-NIL) (Sigma, Oakville, ON), a
speciﬁc inhibitor of iNOS [25], that is, with 20 or 40mg/kg
b o d yw e i g h t - 1 ,1 ,2 ,a n d3d a y sa f t e ri n f e c t i o n .
2.6.UseofFlowCytometryforDNAAnalysisof Trypanosomes.
Ten microliters of blood were collected from the tail of
infected mice (2–6 days post infection) and diluted to
1:50 in an ice-cold solution of tris-buﬀered saline glucose
and 10U/mL heparin (TBSG/heparin) [24]. These parasite-
containing samples were washed 1×with ice-cold TBSG,
that is, centrifuged at 1000×ga t4 ◦C for 10min. About
450μL of the supernatants were removed. The sedimented
cells were resuspended in the remaining ﬂuid with the use of
a pipette. The cells were ﬁxed in ethanol by adding 500μL
40% ice-cold ethanol/PBS, mixed vigorously with a vortex
shaker for 30s, and kept on ice for at least 1h. Then the
samples were spun at 1000×g for 10min and about 400μL
ofthe supernatant ﬂuidswere removed, leaving about100μL
of ethanol/cells in the tube. The cells were resuspended in
theresidual ethanol. Then, 1000μl ofpropidiumiodide(P.I.)
staining solution (Molecular Probes, Eugene, Oregon, USA)
was added to each tube and carefully mixed by a vortex
shaker. The samples were incubated at room temperature in
the dark. Analysis of the samples for DNA content by FACS
was carried out within 24 hours [26, 27]. Trypanosomes
puriﬁed from immunosuppressed, infected CD1 mice were
analyzed by FACS to establish the appropriate gating.
2.7. Statistical Analysis. Data are presented as means ±
standard error (SE). Analysis of Variance (ANOVA) was car-
ried out using Excel software (Microsoft, Santa Monica, CA,
USA).A P value <.05 was considered statistically signiﬁcant.
3.Results
3.1. Induced Nitric Oxide Reduces Parasitemia and Enhances
Survival of T. congolense-Infected Mice. BALB/c mice are
highly susceptible, whereas C57BL/6mice are relatively resis-
tant to T. congolense infections [9, 28]. In iNOS−/− C57BL/6
mice infected with 103 T. congolense, the initial parasitemia
was about 5-fold higher than in infected WT C57BL/6 mice
(Figure 1(a)). In iNOS−/− mice infected with 5 × 106 T.
congolense, the initial parasitemia was about 100-fold higher
than in infected WT mice and, contrary to the infected WT
mice,theiNOS−/− miceinfectedwith5×106 T. congolense did
not control the parasitemia (Figure 1(b)). Whereas the WTJournal of Parasitology Research 3
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Figure 1: iNOS−/− mice are highly susceptible to infections by T. congolense: enhanced parasitemia and reduced survival time. Groups of 5
to 10WT or iNOS−/− C56BL/6 mice were infected with low (103)o rh i g h( 5×106) doses of T. congolense TC13 and parasitemia and survival
time were determined. The initial parasitemia is about 5-fold higher in iNOS−/− mice infected with 103 T. congolense than in infected wild-
type (WT) mice (a) and more than100-fold higher in iNOS−/− mice infected with 5 × 10
6 T. congolense than in infected WT mice (b). WT
mice infected with either dose survive for more than 30 days (the duration of observation period) (c). iNOS−/− mice infected with 103 T.
congolense have a mean survival time of 14±7d a y sa n di N O S −/− mice infected with 5 ×106 T. congolense survive for only 6.8 ±0.1d a y s( c ) .
mice infected with 103 or 5 × 106 T. congolense survived for
more that 30 days (Figure 1(c)) (the duration of observation
period). iNOS−/− mice infected with 103 T. congolense had a
mean survival time of 14±7da ysan diNOS −/− mice infected
with 5 × 106 T. congolense survived for only 6.8 ± 0.1d a y s
(Figures 1(c) and 1(d)). These experiments suggest that the
survival time of iNOS−/− mice infected with T. congolense
might be dose-dependent, a ﬁnding we have never observed
in infections of wild-type mice in our previous work.
3.2. Decreased Production of Nitric Oxide and Enhanced
Synthesis of Cytokines by Spleen Cell Cultures of Infected
iNOS−/− Mice. Spleens collected on day 6 were cultured
for the measurement of synthesis of NO and cytokines
as determined by their levels in the supernatant ﬂuids
of the cultures. The measured levels of nitrite in spleen
cell cultures from iNOS−/− mice infected with either 103
(Figure 2(a))o r5× 106 (Figure 3(a)) parasites were below
the sensitivity of the assay (2.5μM), whereas signiﬁcant
amounts of nitrite were measured in cultures from infected
WT mice. There were no detectable diﬀerences between
cytokine levels in cultures from iNOS−/− versus WT mice
infected with 103 T. congolense,e x c e p tf o rI L - 1 0w h i c hw a s
signiﬁcantly (P<. 05) higher in cultures from iNOS−/− mice
(Figures2(b)–2(f)).ThelevelsofTNF-α(Figure3(b)),MCP-
1( F i g u r e3(d)), IFN-γ (Figure 3(e)), and IL-10 (Figure 3(d))
were signiﬁcantly (P<. 01) higher in cultures from iNOS−/−
than in those from WT mice infected with 5 × 106 T.
congolense. There were no detectable diﬀerences in the levels
of IL-12p40 (Figure 3(f)). Thus, early death of infected
iNOS−/− miceis associatedwith decreasedproductionofNO
but enhanced levels of cytokine synthesis correlated with the
degree of parasitemia (Figures 1(a) and 1(b)).4 Journal of Parasitology Research
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Figure 2: iNOS−/− mice infected with 103 T. congolense produce no detectable nitric oxide but more IL-10 than infected wild-type (WT)
m i c e .M i c ew e r ei n f e c t e dw i t h1 0 3 T. congolense. On day 6 postinfection, spleen cells were cultured at an optimal cell density (5 × 10
6/mL)
for 48 hours. Cytokines in culture supernatants were measured by ELISA, nitrite by the Griess reaction. ∗P<. 05, ∗∗P<. 01.
3.3. L-NIL Given Intravenously at Doses of 20 or 40mg/kg
Body Weight Did Not Enhance Parasitemia of Infected Mice.
L-N6-(1-iminoethyl) lysine (L-NIL) has been shown to be
as p e c i ﬁ ci n h i b i t o ro fi N O S[ 25]. This iNOS inhibitor has
beengiveninthedrinking water[29]orbyinjection[30,31].
We chose to administer L-NIL at dosages of 20 or 40mg/kg
body weight intravenously on days −1, 1, 2, and 3. We
expected that this treatment would enhance parasitemia
since this regimen of administration of L-NIL was eﬀective
in a diﬀerent experimental design of T. congolense infection
[22] (see Discussion). At these dose regimens, however, we
did not observe an eﬀect on the parasitemia (Figure 4(a))
nor complete inhibition of the synthesis of induced NO
by spleen cell cultures of the L-NIL-treated, infected mice
(Figure 4(b)). Thus, it appeared that synthesis of iNOS was
not eﬀectively inhibited by L-NIL in mice in the presence of
high levels of T. congolense.
3.4. Nitric Oxide Inhibits Multiplication of T. congolense
In Vivo. By using simple, reliable methods for staining
nuclear DNA, cell cycle compartment analysis can be
used to measure cell proliferation. We decided to measure
potential diﬀerences of proliferation of trypanosomes in
infected iNOS−/− and WT mice by using DNA staining with
propidium iodide, and subsequent FACS analysis [26, 27].Journal of Parasitology Research 5
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Figure 3: iNOS−/− mice infected with 5 × 106 T. congolense produce no detectable nitric oxide but more TNF-α, IL-10, and IFN-γ than
infected wild-type (WT)mice. Mice were infected with 5×10
6 T. congolense.On day6 postinfection, spleen cells were cultured at an optimal
cell density (5 ×10
6/mL) for 48 hours. Cytokines in culture supernatants were measured by ELISA, nitrite by the Griess reaction. ∗∗P<. 01.
We initially puriﬁed trypanosomes from immunosuppressed
CD1mice,stainedthemwithpropidiumiodideandanalyzed
them by FACS to establish the gating for determining
t h er a t i o so fS + G 2 + Mt oS 1p h a s e so ft h et r y p a n o s o m e s
(Figure 5(a)). We then determined the ratios of S+G2+M
to S1 phases of the trypanosomes in the blood of iNOS−/−
and WT mice infected with 5 × 106 parasites. We found
signiﬁcantly higher ratios of S+G2+M to S1 phases in the
bloodstreamtrypanosomes ofiNOS−/− miceondays5and6
(Figure 5(d)). These ﬁndings indicate that the trypanosomes
in the iNOS−/− mice had a higher rate of proliferation than
the ones in WT mice. These results lead us to the conclusion
that one of the mechanisms of controlling the parasitemia is
due to the cytotoxic eﬀect of NO.
3.5.Infected CD11b−/− Mice Have Enhanced Nitric Oxide Pro-
duction and Enhanced Control of First Parasitemia. We have
previously shown that IgM anti-VSG-mediated phagocytosis
by macrophages inducedmore NOin macrophages obtained
from CD11b−/− mice than in those from wild-type mice. We6 Journal of Parasitology Research
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Figure 4: Treatment of mice with L-NIL, an iNOS-speciﬁc inhibitor, had no eﬀect on parasitemia but a moderate eﬀect on the production
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postinfection. Mice were infected i.p. with 5 × 106 T. congolense TC13 on day 0. Parasitemia (a) was determined. On day 6 postinfection,
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6/mL)for48hours.Nitrite (b) inculture supernatantswasmeasured by theGriess
reaction. ∗∗P ≤ .01; ∗∗∗P ≤ .001.
thus tested the parasitemia in CD11b−/− and wild-type mice
infected with 103 T. congolense. The ﬁrst parasitemia was
signiﬁcantly lower in the CD11b−/− mice and the spleen cell
cultures of the CD11b−/− mice produced more NO but less
MCP-1 than those of the infected wild-type mice (Figure 6).
The subsequent parasitemias were not signiﬁcantly diﬀerent
in the infected two mouse strains (not shown). Considering
that most phagocytosis of trypanosomes during the ﬁrst
parasitemia is due to IgM anti-VSG antibody, the above
observations would suggest that the eﬀect of NO on T.
congolense is more powerful in controlling parasitemia of T.
congolense than phagocytosis mediated by IgM anti-VSG.
4.Discussion
In iNOS−/− mice infected with T. congolense, parasitemia
was signiﬁcantly enhanced and survival time dramatically
reduced (Figure 1), providing strong support for a signif-
icantly protective role of inducible NO in infections by T.
congolense. Thus, these results conﬁrm the ﬁndings reported
by Magez et al. [21]. The degree of disease in T. congolense-
infected iNOS−/− mice appears to be correlated with the
dose of infection (Figures 1, 2,a n d3), a condition we have
never observed in infected WT mice. In WT mice, we merely
observeaninversecorrelationofthedoseofinfectionandthe
prepatent period (Figures 1(a) and 1(b))[ 32]. In iNOS−/−
mice infected with a high dose of T. congolense, production
of nitric oxide was very low but synthesis of cytokines (TNF-
α,M C P - 1 ,I L - 1 0 ,a n dI F N - γ) by spleen cell cultures was
signiﬁcantly enhanced (Figure 3). We interpret the increased
levelsof cytokinesto be an expression of enhancement of the
systemic inﬂammatory response syndrome described by us
previously [33, 34].
Since induced NO exhibits such a crucial role in the
control of parasitemia and survival, it is plausible to assume
that infected WT C57BL/6 mice should become susceptible
to disease if treated with the speciﬁc iNOS inhibitor L-NIL.
Surprisingly, inhibition of iNOS by L-NIL given at doses of
20 or 40mg/kg body weight i.v. to infected WT C57BL/6
mice at days −1, 1, 2, and 3 neither eﬀectively inhibited
all NO synthesis in the spleen nor enhanced parasitemia of
infected mice. A similar treatment was eﬀective in a diﬀerent
experimental design. We found that previous treatment with
an optimal amount of anti-CD25 antibody of susceptible
BALB/c mice subcutaneously infected with T. congolense led
to prevention of parasitemia and disease in the infected mice
[22]. This condition could be reversed by treatment with L-
NIL [22]. We presently have no suﬃcient explanation for
the discrepancy of results obtained with iNOS−/− mice and
iNOS inhibitor in this study. We speculate that the presence
of high levels of T. congolense might, by a yet unknown
mechanism directly or indirectly, interfere with the iNOS-
inhibiting eﬀect of L-NIL.
N Oh a sb e e ns h o w nt op r e v e n tA f r i c a nt r y p a n o s o m e st o
grow in vitro [14, 17]. Thus judging from the experiments
with iNOS−/− mice, it is plausible to assume that NO
does inhibit the multiplication of T. congolense in vivo.
Since the G2:G1 ratios of cells provide insight into the
rate of multiplication of cells [26, 27], we proceeded
to determine the percentages of the blood stages of T.
congolense that were in the S/G2/M versus G1 phase. We did
observe a signiﬁcantly higher ratio of the S/G2/M phases inJournal of Parasitology Research 7
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Figure 5: Higher rate of multiplicationof T. congolense in infected iNOS−/− mice than in infected wild-type mice. Groups of 6 WT C57BL/6
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T. congolense obtained from the blood of infected iNOS−/−
mice (Figure 5), indicating that the parasites had a higher
multiplication rate in the iNOS−/− mice than in the WT
mice. From these observations, we conclude that induced
nitric oxide inhibits multiplication of T. congolense in
infected WT mice in vivo. The experiments do not tell us
where the interaction of trypanosomes and NO might occur.
Thus we might ask the question: where does secreted NO
interact with the intravascular trypanosomes? Phagocytosis
of trypanosomes sensitized by anti-VSG antibodies takes8 Journal of Parasitology Research
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Figure 6: CD11b−/− mice infected with T. congolense have a higher production of nitric oxide and show better control of the initial
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place by macrophages in the liver and spleen [5, 6, 8].
Macrophages are also a major source of induced NO upon
phagocytosis of trypanosomes [7, 14, 17]. The cytotoxic
eﬀect of NO secreted by macrophages in vivo will be
eﬀective at a very short range only, since NO is eﬃciently
neutralized by hemoglobin of red blood cells [35]. During
early infection, there is a stage of the host response when
plasma levels of IgG anti-VSG antibodies are still too low
to mediate phagocytosis of trypanosomes. It is conceivable
that, at this stage, IgG anti-VSG antibodies, especially IgG2a
anti-VSG antibodies [14, 36], might nevertheless be present
in suﬃcient concentration to mediate temporary adherence
of trypanosomes to macrophages. We propose that this
process might result in bringing trypanosomes into close
apposition to macrophages, that is, to Kupﬀer cells in the
liver[5, 6, 8] and to macrophages in the marginal zone of the
spleen [37]. Thus, released NO, in turn, could be suﬃciently
cytotoxic to the temporarily caught parasites to inhibit their
multiplication. This might be analogous to the control of
growth of T. lewisi and T. musculi [38, 39].
We previously found that IgM anti-VSG antibody-
mediated phagocytosisofT. congolense ledto higherNOsyn-
thesis by CD11b−/− macrophages than by WT macrophages
[7]. From those experiments, we concluded that signaling of
inhibition of NO synthesis in WT macrophages might occur
via complement receptor CR3 and not by ingested antigen
intracellularly. We further concluded that this process is
complement-independent.Moleculesofothermicrobeshave
been shown to bind in complement-independent fashion to
the lectin site of CR3, that is diﬀerent from the binding site
of iC3b [40–42]. We found that IgM anti-VSG induces shed-
ding of soluble VSG (sVSG) from T. congolense (Pan et al.,
unpublished). We speculated that the glycan of the sVSG [2]
might bind to the lectin site of CR3.It is relevant to note that
Coller et al. [43]f o u n dt h a tI F N - γ-induced NO production
by a macrophage cell line was reduced after the macrophages
were exposed tosVSG ofT.bruceirhodesiense.Inthiscontext,
we infected CD11b−/− mice with T. congolense.W ef o u n d
enhanced nitric oxide production and enhanced control of
the ﬁrst parasitemia, but not of the later parasitemias, in the
infected CD11b−/− mice as compared to the infected WT
mice. The ﬁrst parasitemia is predominantly controlled by
IgM anti-VSG antibodies. Thus, it would appear that the
cytotoxic eﬀect of NO on T. congolense is more powerful in
controlling parasitemia of T. congolense than phagocytosis
mediated by IgM anti-VSG. It also appears that African
trypanosomes have developed a mechanism to evade the
deleterious eﬀect of NO by inducing an IgM anti-VSG-
mediated inhibition of NO synthesis [7, 14].
In summary, we conclude that in mice infected with T.
congolense,inducedNOcontributestocontrolofparasitemia
by inhibiting the growth of the trypanosomes.
Abbreviations
iNOS: Inducible nitric oxide synthase
NO: Nitric oxide
VSG: Variant surface glycoprotein
L-NIL: L-N6-(1-imminoethyl) lysine.
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